BriefTea
Every story in sixty words
Get the free app no ads · no paywallHealth · 29 June 2026
Pexels / www.kaboompics.com
Scientists are exploring how a simple blood test might help tailor weight-loss treatments for severe obesity patients. The test measures two hormones, GLP-1 and GIP, to predict how well drugs like semaglutide or tirzepatide might work. This preliminary study suggests personalising treatment could lead to better weight loss and health improvements.
Reported by News-Medical · How we write briefs
Understand this story
What's a Test match? What is a 'Test' match?More briefs
HealthGreat Ormond Street's Same-Day Test Finds Hidden Infections in Sick Children HealthImmune cell found to kill small cell lung cancer in lab tests HealthDiabetics sleeping 8+ hours face nearly double kidney disease risk HealthNo perfect age to start HRT, but benefits peak before 60, experts say HealthOver 12,000 fake weight-loss pens worth £2m seized in Birmingham raid HealthTrans patients in England to go on wards matching birth sex More health stories → Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.